Verex Laboratories, Inc. (VRXL/VRXL.PK) Wrap Up:

Verex Laboratories, Inc. engages in the business of developing and marketing non-prescription and prescription drug products utilizing constant release rate drug delivery systems. The company has been in early stage development of a sustained drug delivery system that has shown potential for oral administration of drugs of macromolecule size, particularly proteins, polypeptides, and polysaccharides, which have low or no bioavailability when given orally. Its Veraderm is a wound dressing, made from a proprietary formulation of polymers that, when applied superficially to an open wound, can enhance healing while diminishing the chances of infection. In addition, the company offers a treatment ...